(Q38912273)

English

Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 September 2017

Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis (English)

1 reference

Europe PubMed Central

7 September 2017

0 references

trypanosomiasis

0 references

African trypanosomiasis

0 references

author name string

Blum J

1

1 reference

Europe PubMed Central

7 September 2017

Nkunku S

2

1 reference

Europe PubMed Central

7 September 2017

Burri C

3

1 reference

Europe PubMed Central

7 September 2017

publication date

1 May 2001

1 reference

Europe PubMed Central

7 September 2017

Tropical Medicine and International Health

1 reference

Europe PubMed Central

7 September 2017

6

1 reference

Europe PubMed Central

7 September 2017

5

1 reference

Europe PubMed Central

7 September 2017

390-400

1 reference

Europe PubMed Central

7 September 2017

Human African trypanosomiasis (T.b. gambiense): a study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2001.00710.X

21 January 2018

Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2001.00710.X

21 January 2018

Reactivation of Chagas' disease in patients with AIDS: report of three new cases and review of the literature

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2001.00710.X

21 January 2018

Subcurative chemotherapy and fatal post-treatment reactive encephalopathies in African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2001.00710.X

21 January 2018

Chemotherapy of Trypanosoma brucei infection of the central nervous system: the use of a rapid chemotherapeutic regimen and the development of post-treatment encephalopathies.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2001.00710.X

21 January 2018

Investigations of the metabolites of the trypanocidal drug melarsoprol

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2001.00710.X

21 January 2018

African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2001.00710.X

21 January 2018

Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2001.00710.X

21 January 2018

Visceral leishmaniasis and HIV-1 co-infection in southern France

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2001.00710.X

21 January 2018

Clinical study of an organic arsenical, melarsoprol, in patients with advanced leukemia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2001.00710.X

21 January 2018

Post-treatment hind-leg paralysis in mice infected with Trypanosoma brucei brucei: a light microscopic study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2001.00710.X

21 January 2018

Identifiers

10.1046/J.1365-3156.2001.00710.X

1 reference

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38912273&oldid=1795853942"